Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Johnson & Johnson - Optimising the personalisation of GU cancer care

FGFR testing: Why, how, when?

Date

13 Sep 2024

Session

Johnson & Johnson - Optimising the personalisation of GU cancer care

Topics

Tumour Site

Urothelial Cancer

Presenters

Viktor Gruenwald

Authors

V. Gruenwald

Author affiliations

  • Clinic For Cancer Research And Clinic For Urology, University Hospital Essen Westdeutsches Tumorzentrum, 45147 - Essen/DE

Resources

This content is available to ESMO members and event participants.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.